Clalis capsules recall
Clalis capsules, 50 mg, 6 -count bottle ( labeling is in foreign language)
Why was Clalis capsules recalled?
Marketed without an Approved NDA/ANDA: Laboratory analysis conducted by the FDA has determined that the products was found to contain sildenafil, an undeclared active pharmaceutical ingredient.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
All lots
- Product
- Clalis capsules, 50 mg, 6 -count bottle ( labeling is in foreign language)
- Recalling firm
- Fabscout Entertainment, Inc
- Distribution
- Nationwide and France
- Recall date
- March 26, 2014
- Classification
- Class I
- Status
- Terminated
- Agency
- FDA (drug)